GCM
CORT icon

Graham Capital Management’s Corcept Therapeutics CORT Stock Holding History

Graham Capital Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,281
Closed -$669K – 1334
2024
Q4 		$669K Sell
13,281
-8,223
-38% -$431K 0.02% 635
2024
Q3 		$995K Buy
21,504
+5,185
+32% +$184K 0.03% 467
2024
Q2 		$530K Buy
+16,319
New +$447K 0.02% 570
2024
Q1 		– Sell
-8,094
Closed -$263K – 1100
2023
Q4 		$263K Buy
+8,094
New +$222K 0.01% 764
2023
Q1 		– Sell
-11,945
Closed -$243K – 1094
2022
Q4 		$243K Buy
+11,945
New +$299K 0.01% 941
2022
Q2 		– Sell
-43,284
Closed -$974K – 1044
2022
Q1 		$974K Buy
+43,284
New +$921K 0.04% 314

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return